January 1, 2025By Sarah Azarchi, MDStrategies to Reduce Antipsychotic-Induced HyperprolactinemiaFive strategies to reduce prolactin on antipsychotics tested in this meta-analysis
January 1, 2025By Nicholas J. Nissen, MDADHD: Beyond StimulantsStimulants may hold the prize for effect size in ADHD, but nonstimulants have advantages for the right patient. Nicholas Nissen shows us how to use five medications, two supplements, and lifestyle approaches in ADHD.
January 1, 2025By Jason Mallo, DOHow to Diagnose Borderline Personality DisorderWe show you how to ask about borderline criteria and how to convey the diagnosis to the patient.
November 1, 2024By Alex Evans, PharmD, MBA.Lithium, Valproate Have Low (and Similar) Risk of Kidney Injury
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
General PsychiatryPsychopharm Secrets: What Patients Won’t Tell YouHow to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.Listen now
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729532347)
-_-Benefits-Side-Effects-and-Review-of-Trials_Thumb.jpg?1727894306)
